BioMarin shares up 30% on treatment result
November 05, 2012 at 12:36 PM EST
Shares of biotechnology company BioMarin climb more than 30% after positive results from treatment for rare disorder
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.